Sign in Pull a receipt

TCRT

Alaunos Therapeutics, Inc.

Healthcare · Biotechnology

$297.07 sample

+4.50 (+1.54%) 1D

Market cap

$1.26T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-20

Alerts

8

Price$297.07 +0.89% 3M daily closessample

302.30278.97

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Director
Oct 20SECForm 144 filed
Oct 14SEC8-K filed: material event
Oct 07SEC8-K filed: material event
Oct 01INSInsider buy: Chief Executive Officer
Sep 22INSInsider sell: Chief Financial Officer
Sep 11SEC8-K filed: material event
Sep 07INSInsider buy: General Counsel

Sign up to see the real TCRT record →

Company facts

SEC EDGAR registration

Name: Alaunos Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -26sample, -100 to +100
Reporting currency: USD

Who is positioning in TCRT

sample

Insiders: 7 insider transactions over 90 days, net selling, $778.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 38 funds hold $19.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$28.0B +16.0% y/y

Q4 2024Q3 2026

Inventory$16.9B +11.8% y/y

Q4 2024Q3 2026

Accounts receivable$13.1B +13.1% y/y

Q4 2024Q3 2026

Total debt$34.1B +8.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $438.2B +12.0% 3M
Sample peer B: $612.3B +14.1% 3M
Sample peer C: $1.10T -9.7% 3M
Sample peer D: $1.25T +12.9% 3M
Sample peer E: $229.7B -12.1% 3M